U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
(Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co’s lung cancer drug Alimta. Shares of…
FDA says Mylan’s EpiPen is in shortage
(Reuters) – U.S. regulators said on Wednesday that Mylan NV’s (MYL.O) EpiPen products are in shortage, due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy…
FDA says manufacturing delays are constraining EpiPen supply
NEW YORK (Reuters) – The U.S. Food and Drug Administration added Mylan NV’s (MYL.O) EpiPen to its list of drugs in shortage on Wednesday, saying that manufacturing delays were creating…
Canada seeks U.S. help to solve EpiPen shortage
TORONTO (Reuters) – Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.’s EpiPen emergency allergy antidote amid a growing…